Next Article in Journal
Exogenous RNAs for Gene Regulation and Plant Resistance
Next Article in Special Issue
Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
Previous Article in Journal
Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species’ Release
Previous Article in Special Issue
ARNi: A Novel Approach to Counteract Cardiovascular Diseases
Review

C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature

by *,† and
William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK
*
Author to whom correspondence should be addressed.
These authors equally contributed to the work.
Int. J. Mol. Sci. 2019, 20(9), 2281; https://doi.org/10.3390/ijms20092281
Received: 15 April 2019 / Revised: 30 April 2019 / Accepted: 2 May 2019 / Published: 8 May 2019
C-type natriuretic peptide (CNP) is an autocrine and paracrine mediator released by endothelial cells, cardiomyocytes and fibroblasts that regulates vital physiological functions in the cardiovascular system. These roles are conveyed via two cognate receptors, natriuretic peptide receptor B (NPR-B) and natriuretic peptide receptor C (NPR-C), which activate different signalling pathways that mediate complementary yet distinct cellular responses. Traditionally, CNP has been deemed the endothelial component of the natriuretic peptide system, while its sibling peptides, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), are considered the endocrine guardians of cardiac function and blood volume. However, accumulating evidence indicates that CNP not only modulates vascular tone and blood pressure, but also governs a wide range of cardiovascular effects including the control of inflammation, angiogenesis, smooth muscle and endothelial cell proliferation, atherosclerosis, cardiomyocyte contractility, hypertrophy, fibrosis, and cardiac electrophysiology. This review will focus on the novel physiological functions ascribed to CNP, the receptors/signalling mechanisms involved in mediating its cardioprotective effects, and the development of therapeutics targeting CNP signalling pathways in different disease pathologies. View Full-Text
Keywords: natriuretic peptide; vascular; endothelial cell; cardiomyocyte; fibroblast; inflammation; heart failure; hypertension; angiogenesis natriuretic peptide; vascular; endothelial cell; cardiomyocyte; fibroblast; inflammation; heart failure; hypertension; angiogenesis
Show Figures

Figure 1

MDPI and ACS Style

Moyes, A.J.; Hobbs, A.J. C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature. Int. J. Mol. Sci. 2019, 20, 2281. https://doi.org/10.3390/ijms20092281

AMA Style

Moyes AJ, Hobbs AJ. C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature. International Journal of Molecular Sciences. 2019; 20(9):2281. https://doi.org/10.3390/ijms20092281

Chicago/Turabian Style

Moyes, Amie J., and Adrian J. Hobbs. 2019. "C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature" International Journal of Molecular Sciences 20, no. 9: 2281. https://doi.org/10.3390/ijms20092281

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop